Azathioprine oral dispersible - Mitsubishi Tanabe

Drug Profile

Azathioprine oral dispersible - Mitsubishi Tanabe

Alternative Names: Azanin; JP azathioprine tablets

Latest Information Update: 02 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Developer Mitsubishi Tanabe Pharma Corporation
  • Class Antirheumatics; Purines; Small molecules; Thionucleosides
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Connective tissue disorders; Crohn's disease; Dermatomyositis; Polymyositis; Scleroderma; Systemic lupus erythematosus; Transplant rejection; Ulcerative colitis; Vasculitis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 02 Jun 2011 Registered for Connective tissue disorders in Japan (PO)
  • 02 Jun 2011 Registered for Dermatomyositis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top